Specification |
Product name: | Recombinant human MYO antigen |
Source: | E.coli derived |
Accession #: | P02144 |
SDS-PAGE: | 15-25kDa, reducing conditions |
Construction: | MYO with 6His tag at N-terminal |
Predicted Molecular Mass: | 18kDa |
Activity: | Immunoreactivity was confirmed by reacting with monoclonal antibodies specific to human MYO. |
Application: | ELISA, immunology, others unspecified. |
Form: | Liquid |
Formulation: | 20 mM Tris, 300 mM NaCl, pH 8.0 |
Stability & Storage: | Stable at -80°C |
Shipping condition: | The product is shipped on ice pack.Upon receiving, store it immediately at the recommended temperature. |
Conc. Determined: | BCA |
Purity: | >98% |
1. ASL SK, RAHIMZADEGAN M. The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches[J]. Journal of Pharmaceutical and Biomedical Analysis, 2022,211: 114624.
2. SCRIVNER O, FLETCHER E, HOFFMANN C, et al. Myoglobinemia, Peripheral Arterial Disease, and Patient Mortality[J]. Journal of the American College of Surgeons, 2023,236(4): 588-598
3. WU M, WANG C, ZHONG L, et al. Serum myoglobin as predictor of acute kidney injury and 90-day mortality in patients with rhabdomyolysis after exertional heatstroke: an over 10-year intensive care survey[J]. Int J Hyperthermia, 2022,39(1): 446-454
新品速递
Recombinant human MYO antigen
了解更多Recombinant human MPO antigen (MPO-H)
了解更多Recombinant human GDF-15 antigen
Catalog#:
Reactivity:
Source:E.coli derived
Application:ELISA, immunology, others unspecified.
了解更多Recombinant human cTnI antigen
Catalog#:
Reactivity:
Source:E.coli derived
Application:ELISA, immunology, others unspecified.
了解更多全自动干式荧光免疫分析仪Smart i FIA 120
了解更多
加入购物车